NetworkNewsBreaks – SeeThruEquity Updates Great Basin Scientific, Inc. (GBSN) Coverage
SeeThruEquity has updated its coverage on Great Basin Scientific, Inc. (OTCQB: GBSN) stock following the company’s news that it has received FDA 510(k) clearance for its new Stool Bacterial Pathogens Panel (SBPP) for foodborne illness. FDA clearance now allows the company to begin actively marketing SBPP to its current customer base of over 230 hospitals and labs, as well as new customers. Management expects the SBPP to be the flagship test moving forward. SeeThruEquity’s previously issued price target of $1.00 on shares of the company’s stock remains unchanged. For more information, visit www.gbscience.com About Great Basin Scientific Great Basin Scientific is…







